“Improved Nrf2 Activator Effective in Multiple Sclerosis Animal Models with Minimal Off-Target Effects”

https://pubmed.ncbi.nlm.nih.gov/38116420

A new type of Nrf2 activator with improved electrophilicity and plasma stability shows efficacy in animal models of multiple sclerosis and has minimal off-target effects.